Dewi Marianthi

Molecular docking analysis of Citrus aurantifolia peel bioactive compounds against fshr, androgen receptor, and PCSK4 in hyperlipidemia-associated male reproductive dysfunction

The selected C. aurantifolia peel compounds showed predicted interactions with the three target proteins; however, molecular docking alone does not establish nutraceutical efficacy, bioavailability, safety, receptor activation, or clinical benefit, however, further experimental validation is required.